European journal of dermatology: EJD (EUR J DERMATOL)

Publications in this journal

• Article: Residents'corner July 2012. Residents' editorial choice.

  Tiago Torres, Emmanuella Guenova, Laurence Feldmeyer, Audrey Nosbaum
  European journal of dermatology: EJD 08/2012; 22(4):584-5.
• Article: Misdiagnosis and patient negation: a case of universal vitiligo.

  Roberta Colucci, Meena Arunachalam, Federica Dragoni, Massimiliano Galeone, Samantha Berti, Siliva Moretti
  European journal of dermatology: EJD 05/2012; 22(3):423-4.
• Article: Human papilloma virus type 16-associated verruca vulgaris on the digits with multiple cancerous anogenital lesions.

  Chieko Ibusuki, Makoto Kunisada, Kanako Ogura, Tetsuya Ikeda, Yoshiko Oda, Chikako Nishigori
  European journal of dermatology: EJD 05/2012; 22(3):400-1.
• Article: Unilateral telangiectasia macularis eruptiva perstans with a clear demarcation at the midline of the trunk.

  Shinji Noda, Jason B Lee, Kehua Li, Laurel Schwartz
  European journal of dermatology: EJD 05/2012; 22(3):407-8.
• Article: 11th Annual LVMH Recherche Symposium: skin rejuvenation.

  Frédéric Bonté
  [show abstract] [hide abstract]
  ABSTRACT: The 11(th) Annual LVMH Recherche Scientific Symposium was held in London on October 27(th), into the warmth of the distinguished British Library, with nearly 150 industry and research attendees. The meeting organized by LVMH Recherche was centered on the theme of skin rejuvenation. The current state of play for rejuvenation research was summarized, and then advances in the science of skin aging and rejuvenation therapies were discussed in detail. Personalized genomics and current and prospective translational therapies were presented, followed by a clever linking of multiple global theories towards a cohesive plan for future goals in rejuvenation research.
  European journal of dermatology: EJD 05/2012; 22(3):432-6.
• Article: Suspected Nagashima-type palmoplantar keratosis with atypical hyperkeratotic lesions on the ears.

  Yumi Nonomura, Atsushi Otsuka, Yoshiki Miyachi, Kenji Kabashima
  European journal of dermatology: EJD 05/2012; 22(3):392-3.
• Article: CD8-positive pityriasis lichenoides-like mycosis fungoides.

  Eun Byul Cho, Sung Hwan Youn, Eun Joo Park, In Ho Kwon, Kwang Ho Kim, Kwang Joong Kim
  European journal of dermatology: EJD 05/2012; 22(3):415-6.
• Article: Seronegative rheumatoid nodulosis: a new case report.

  Yue-Ping Zeng, Tao Qu
  European journal of dermatology: EJD 05/2012; 22(3):425-6.
• Article: Netherton syndrome showing a large clinical overlap with generalized inflammatory peeling skin syndrome.

  Muhammad Farooq, Mazen Kurban, Ossama Abbas, Abdul-Ghani Kibbi, Atsushi Fujimoto, Hiroki Fujikawa, Yutaka Shimomura
  European journal of dermatology: EJD 05/2012; 22(3):412-3.
• Article: Cytokine and chemokine ligand expression in cutaneous lupus erythematosus.

  Thilo Gambichler, Zanna Genc, Marina Skrygan, Nina Scola, Christian Tigges, Sarah Terras, Falk G Bechara, Alexander Kreuter
  [show abstract] [hide abstract]
  ABSTRACT: There is increasing evidence that cytokines as well as chemokines are important players in the pathogenesis of lupus erythematosus (LE). We aimed to compare cytokine and chemokine profiles in different types of cutaneous LE. We investigated lesional mRNA and protein expression of various cytokines and chemokines in patients with chronic discoid LE (CDLE, n=15), subacute cutaneous LE (SCLE, n=11), and lupus erythematosus tumidus (LET, n=21). TNF-α, INF-γ, TGF-β, IL-6, IL-10, IL-12p40, CXCL9, and CXCL10 mRNA expression were significantly increased in SCLE when compared to CDLE. Moreover, LET also showed significantly increased mRNA expression of TNF-α, TGF-β, IL-10, IL-12p40 and CXCL9, as compared to CDLE. In all LE subtypes, CXCL9 and CXCL10 mRNA expression significantly correlated with INF-γ mRNA expression, as indicated by r-values ranging from 0.71 - 0.87. Immunohistochemistry for TNF-α, INF-γ, and IL-10 gave support to our RT-PCR results. In conclusion, our results suggest that T helper 1, as well as T helper 2 cytokines are differentially expressed in CDLE, SCLE, and LET. Compared to CDLE, the highest cytokine and chemokine ligand profiles are found in SCLE followed by LET. Our correlation studies also support the importance of an IFN-driven inflammation in cutaneous LE.
  European journal of dermatology: EJD 05/2012; 22(3):319-23.
• Article: Neutrophilic panniculitis with non-caseating granulomas in a Crohn's disease patient.

  Youichi Ogawa, Rui Aoki, Kazutoshi Harada, Takamitsu Matsuzawa, Takashi Inozume, Naotaka Shibagaki, Tatsuyoshi Kawamura, Shinji Shimada
  European journal of dermatology: EJD 05/2012; 22(3):404-5.
• Article: Gypsy moth-induced dermatitis: a hospital review and community survey.

  Takayuki Kikuchi, Ken Kobayashi, Kiyomi Sakata, Toshihide Akasaka
  [show abstract] [hide abstract]
  ABSTRACT: Lymantria dispar (gypsy moth [GM]) is found in most temperate forests. Although GM caterpillars are known to cause outbreaks of dermatitis, there have been few clinical/epidemiological studies of this problem. Here, we investigated GM caterpillar-induced health problems in a heavily infested area. We reviewed the records of 229 GM caterpillar-induced dermatitis patients treated at Kuzumaki Hospital and conducted a questionnaire survey covering all 2,891 households (7,770 residents) in Kuzumaki town. Affected areas were located primarily on the neck and arms. 180 patients (79%) did not notice direct contact with GM caterpillars on their affected areas. There were no significant differences in demographics, history, and symptoms between the group of patients with direct contact and those without direct contact. In the questionnaire survey, of the 4,871 people who responded (63%), 2039 people (42%) reported having dermatitis. When the data were adjusted for age, gender was not associated with dermatitis; however, the age groups 70-79 years and ≥80 years showed lower incidences of dermatitis. Those experiencing similar dermatitis the previous year had a significantly higher occurrence of dermatitis: odds ratio (OR)=42.4, 95% confidence interval (CI): 33.5-53.6. Thus, when GM infestation occurs, physicians should expect an outbreak of dermatitis.
  European journal of dermatology: EJD 05/2012; 22(3):384-90.
• Article: The syndrome of inappropriate antidiuretic hormone secretion (SIADH) associated with metastatic malignant melanoma.

  Miho Ueda, Yuichiro Endo, Yo Kaku, Hideaki Tanizaki, Hiroaki Fujisawa, Miki Tanioka, Yoshiki Miyachi
  European journal of dermatology: EJD 04/2012; 22(3):411-2.
• Article: High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid.

  Georgios Gaitanis, Ioannis Alexis, Sygkliti-Henrietta Pelidou, Irene F Gazi, Athanasios P Kyritsis, Moses S Elisaf, Ioannis D Bassukas
  [show abstract] [hide abstract]
  ABSTRACT: High-dose intravenous immunoglobulin (IVIg) has only been sporadically used in the treatment of bullous pemphigoid (BP), as it is suggested as an adjuvant to systemic corticosteroids in progressive disease or when life-threatening complications are of concern with other therapeutic interventions. The aim of the present study was to report our observations in the treatment of adult BP patients with IVIg, in association with a focused literature review. In our Department we identified five patients (4 women, 1 man) who had received IVIg for BP relatively early in the course of their disease. These cases were added to the 36 adequately documented ones reported in the literature. Most of these patients (33/41) responded to treatment with IVIg and 7/33 responders remained clear one year after the onset of IVIg. However, the time for effective disease control after IVIg treatment depended positively on disease duration before treatment (P<0.01). In conclusion, despite the limited experience with its use, IVIg seems to be a useful therapeutic alternative to conventional modalities for selected BP patients, particularly if it is initiated promptly after BP diagnosis.
  European journal of dermatology: EJD 04/2012; 22(3):363-9.
• Article: Absence of cutaneous symptoms of pseudoxanthoma elasticum at the immobile joint of a stroke patient.

  Mikiko Michigami, Hitoshi Kudo, Akira Iwanaga, Atsushi Utani
  European journal of dermatology: EJD 04/2012; 22(3):403-4.
• Article: Emergencies in dermatology outpatient clinics: our experience in Spain.

  Marina Rodríguez-Martín, Miguel Saez, Nayra Merino de Paz, Patricia Contreras Ferrer, Mar Pestana Eliche, Antonio Noda Cabrera
  European journal of dermatology: EJD 04/2012; 22(3):408-9.
• Article: Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.

  Edoardo Zattra, Anna Belloni Fortina, Mauro Alaibac
  European journal of dermatology: EJD 04/2012; 22(3):416-7.
• Article: Syringocystadenocarcinoma papilliferum in situ of the penis.

  Mathew A Plant, Shachar Sade, Collin Hong, Danny M D Ghazarian
  European journal of dermatology: EJD 04/2012; 22(3):405-6.
• Article: Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.

  Kumiko Sasada, Jun-ichi Sakabe, Aiko Tamura, Akira Kasuya, Takatoshi Shimauchi, Taisuke Ito, Satoshi Hirakawa, Yoshiki Tokura
  European journal of dermatology: EJD 04/2012; 22(3):402-3.
• Article: Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis.

  Salvador Arias-Santiago, Jacinto Orgaz-Molina, Luisa Castellote-Caballero, Miguel Ángel Arrabal-Polo, Sonia García-Rodriguez, Rubén Perandrés-López, José Carlos Ruiz, Ramón Naranjo-Sintes, Mercedes Zubiaur, Jaime Sancho, Agustín Buendía-Eisman
  [show abstract] [hide abstract]
  ABSTRACT: Chronic inflammation plays an important role in the development of cardiovascular risk factors. Although the prevalence of comorbidities and cardiovascular events has been described in patients with psoriasis, few studies have examined subclinical atherosclerosis in psoriasis patients. Our objective was to investigate the prevalence of atheroma plaques in patients with severe psoriasis compared with control subjects and to analyze the association with metabolic syndrome, homocysteine levels and inflammatory parameters. Patients and Methods: This case-control study included 133 patients, 72 with psoriasis and 61 controls consecutively admitted to the outpatient clinic in Dermatology Departments (Granada, Spain.) Carotid atheroma plaques were observed in 34.7% of the psoriatic patients versus 8.2% of the controls (p=0.001) and metabolic syndrome was diagnosed in 40.3% of the psoriatic patients versus 13.1% of the controls (p<0.001). Significantly higher mean values of insulin, aldosterone, homocysteine and acute phase parameters (fibrinogen, D-dimer, C reactive protein and erythrocyte sedimentation rate) were found in psoriatic patients. Binary logistic regression showed a strong association between psoriasis and atheroma plaque and metabolic syndrome after controlling for confounding variables. Limitations: The absence of longitudinal quantification of metabolic syndrome parameters and intima-media thickness in psoriatic patients. The chronic inflammation and hyperhomocysteinemia found in psoriatic patients may explain the association with atheroma plaque and metabolic syndrome. Cardiovascular screening by metabolic syndrome criteria assessment and carotid ultrasound in psoriasis may be useful to detect individuals at risk and start preventive treatment against the development of cardiovascular disease.
  European journal of dermatology: EJD 04/2012; 22(3):337-44.